Coronavirus
The US Has Approved Gilead’s Antiviral Drug Remdesivir To Treat Patients With COVID-19
(Reuters) – The U.S. Food and Drug Administration (FDA) has granted authorization to Gilead Sciences Inc (GILD.O) for emergency use of its experimental antiviral drug remdesivir to treat patients with COVID-19, it said in a letter to Gilead.
During a meeting in the Oval Office with President Donald Trump, Gilead Chief Executive Daniel O’Day called the move an important first step and said the company was donating 1.5 million vials of the drug to help patients.
Gilead said on Wednesday the drug had helped improve outcomes for patients with COVID-19, the disease caused by the coronavirus, and provided data suggesting it worked better when given earlier in the course of infection.
The closely watched drug has moved financial markets in recent weeks, following the release of several studies that painted a mixed picture of its effectiveness.
Vice President Mike Pence said the 1.5 million vials would start being distributed to hospitals on Monday.
Kenya Insights allows guest blogging, if you want to be published on Kenya’s most authoritative and accurate blog, have an expose, news TIPS, story angles, human interest stories, drop us an email on [email protected] or via Telegram
Kenya Airways Sinks Into Deeper Turbulence As American Supplier Sues In New York Court Over Sh129 Million Unpaid Debts
Kenyan player wins a Ksh3.2 million jackpot
IEBC Sets August 10 Date For 2027 General Election
Furious Ruto Lashes Out at Gideon Moi Over Repeated ‘Blackmail, Extortionist’ Headlines on The Standard and KTN
Mombasa Gripped by ‘Male Organ Theft’ Panic as Social Media Fuels Mob Attacks and Fear
TOO MUCH PR, NOTHING TO SEE: How Gladys Wanga Built a Perfect Story of Transformation While Homa Bay Bled
Netanyahu Says Israel Must ‘Break Free from Dependence’ After Tensions With Trump Administration
Niger pulls Out Of International Criminal Court After Calling It Neo-Colonialist
Kenya Awards Sh154 Billion JKIA Upgrade Tender To Chinese Firm CRBC
The Untouchable: How KURA’s Silas Kinoti Has Survived A Decade Of Corruption Storms While Kenya’s Roads Bled
Businessman Philip Waithaka Kinuthia’s Minor Son Allegedly Drove Drunk, Killed Two Peponi Students in Ngong Road Horror Crash as Claims of Cover-Up Intensify
Inside NCBA’s Decline: How a Banking Giant Lost Its Strategic Edge
South Sudan: Adut Salva Kiir’s Shadow Treasury Exposed
Cement, Cash and Courts: How the Hashu Dynasty Crushed the Ramji Brothers for Fourteen Years and Why the Walls Are Now Closing In
Standard Chartered Ghosts Haunt Joshua Oigara At Stanbic As Whistleblower Spills Beans
Inside The Urban Planning Cartel That Owns Nairobi
THE VULTURE AND THE SCHEME How Nairobi West Hospital Became the Most Dangerous Institution in Kenya’s SHA Ecosystem and Why the Books Must Be Audited Now
The President’s Daughter and The Missing Witness: How Adut Salva Kiir’s Shadow Treasury Silenced Its Most Dangerous Critic
How Adil Popat Saved His Empire On The Eve Of Imperial Bank Collapse and Why Kenya’s Mainstream Media Buried The Story
Why John Ngumi Is Running From the EACC and Why the Sh415 Million Payday May Be the Least of His Worries
-
News1 week agoBusinessman Philip Waithaka Kinuthia’s Minor Son Allegedly Drove Drunk, Killed Two Peponi Students in Ngong Road Horror Crash as Claims of Cover-Up Intensify
-
Africa2 weeks agoSouth Sudan: Adut Salva Kiir’s Shadow Treasury Exposed
-
Investigations7 days agoTHE VULTURE AND THE SCHEME How Nairobi West Hospital Became the Most Dangerous Institution in Kenya’s SHA Ecosystem and Why the Books Must Be Audited Now
-
Business2 weeks agoHow Adil Popat Saved His Empire On The Eve Of Imperial Bank Collapse and Why Kenya’s Mainstream Media Buried The Story
-
Business2 weeks agoWhy John Ngumi Is Running From the EACC and Why the Sh415 Million Payday May Be the Least of His Worries
-
Business3 days agoBURRIED TWICE: The Victoria Bank CEO Yogesh Pattni Files
-
Business6 days agoInside the Billion-Shilling Betrayal: How Senior Treasury Officials Plundered a UN Poverty Fund and Built a Real Estate Empire on the Backs of Kenya’s Rural Poor
-
Business1 week agoThe Listing That Doesn’t Lie: What the Market Isn’t Saying About Family Bank’s NSE Debut